Q&A with Belluscura CEO Robert Rauker

09:03, 30th June 2022

Launching world beating portable oxygen concentrators at a time when there is a major industry shortage, is a perfect way of winning market share. That is exactly what Belluscura #BELL is doing alongside adding a new direct to consumer channel to complement its existing distributor led model.

In this latest interview, CEO Bob (Robert) Rauker takes Vox Markets through:

Current market demand. Start  
New features offered by the latest X-PLOR device. 03:20  
Case study to illustrate patient benefits. 06:25  
Value of data aggregation. 08:25  
Expansion of production. 10:40  
Strategic rationale of DTC proposition. 12:30  
Extra resource required. 19:00  
Planned distribution outside the US. 20:40  
Newsflow going forward 20:40  
Future product launch. 23:20  
Innovation cycle. 25:50

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist